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A B S T R A C T
Edible seaweeds are valuable because of their organoleptic properties and complex polysaccharide content. A
study was conducted to investigate the potential of dried edible seaweed extracts, its potential phenolic com-
pounds and alginates for α-amylase inhibitory eﬀects. The kinetics of inhibition was assessed in comparison with
acarbose. The methanol extract of Laminaria digitata and the acetone extract of Undaria pinnatiﬁda showed
inhibitory activity against α-amylase, IC50 0.74 ± 0.02mg/ml and 0.81 ± 0.03mg/ml, respectively; both
showed mixed-type inhibition. Phenolic compound, 2,5-dihydroxybenzoic acid was found to be a potent in-
hibitor of α-amylase with an IC50 value of 0.046 ± 0.004mg/ml. Alginates found in brown seaweeds appeared
to be potent inhibitors of α-amylase activity with an IC50 of (0.075 ± 0.010–0.103 ± 0.017) mg/ml, also a
mixed-type inhibition. Overall, the ﬁndings provide information that crude extracts of brown edible seaweeds,
phenolic compounds and alginates are potent α-amylase inhibitors, thereby potentially retarding glucose lib-
eration from starches and alleviation of postprandial hyperglycaemia.
1. Introduction
Foods with a high glycaemic index (GI), such as simple carbohy-
drates, are rapidly digested and cause a rise in blood glucose levels
(Opperman, Venter, Oosthuizen, Thompson, & Vorster, 2004). En-
during high blood glucose levels, known as hyperglycaemia, precedes
type 2 diabetes mellitus (T2DM) (Oh, 2014). Dietary changes, such as
maintenance of a low dietary GI, may aid in the prevention and man-
agement of hyperglycaemia. Another method to control blood glucose
levels is through bioactive food components acting on the liberation of
glucose during digestion. Inhibiting enzymes, such as α-amylase, is one
such method for slowing down glucose liberation. It has previously
been suggested that management of hyperglycaemia by inhibition of α-
amylase may be used for the treatment or prevention of T2DM (Wu
et al., 2011). Alpha-amylase found in pancreatic juice and saliva plays a
signiﬁcant role in the digestion of polysaccharides into maltose and
glucose.
Seaweeds are marine algae that are commonly used as vegetables in
Asian countries. Seaweeds are also used as medicines and for other
therapeutic applications, while in Western countries they are used as
functional ingredients in foods and beverages (Gupta & Abu-Ghannam,
2011; Mabeau & Fleurence, 1993). Numerous studies have shown that
seaweeds have signiﬁcant nutritional value as well as potential health
beneﬁts. Seaweeds contain minerals, nutrients and non-nutrient com-
ponents, such as phenolic compounds and terpenoids (Stengel, Connan,
& Popper, 2011; Syad, Shunmugiah, & Kasi, 2013). In addition, sea-
weeds contain complex polysaccharides (alginate, carrageenan, fu-
coidan, agar, cellulose or xylan), which make up 30–71% of their dry
weight (Fleurence et al., 2012; O’Sullivan et al., 2010). A study carried
out in stable diabetes patients revealed that seaweed ﬁbre (alginate)
decreased the postprandial rise of blood glucose and insulin levels
(Torsdottir, Alpsten, Holm, Sandberg, & Tölli, 1991). Other more recent
studies reported that fucoidan and cellulose were showing α-amylase
inhibitory activity in vitro (Dhital, Gidley, & Warren, 2015; Kim, Rioux,
& Turgeon, 2015). Seaweeds are also known to have a low lipid content,
only ∼2.3% of their dry weight (Dawczynski, Schubert, & Jahreis,
2007). Since seaweeds contain complex polysaccharides, which are
resistant to enzymatic degradation by enzymes in the human body but
undergo some degree of fermentation by the gut microbiota, con-
sumption will slow down the release of absorbable monosaccharides,
such as glucose (Mohamed, Hashim, & Rahman, 2012; Ramnani et al.,
2012).
As seaweeds contain chemical constituents with potential for in-
hibition of α-amylase, these foods and food constituents might be
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